Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA3R4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,871
Award facts
- Contract value 100% obligated
- $33,870.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $33.87K delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 26, 2026, for the supply of Zepbound 10 mg/0.5 mL pen auto-injectors. The contract, which is a firm fixed-price delivery order with no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 27, 2026. This award is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.99M through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen maintains a substantial role in the federal pharmaceutical supply chain, competing on a full and open basis to deliver critical medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contractor's track record demonstrates consistent capability in fulfilling federal medical supply requirements through various delivery orders involving brand-name medications, generic drugs, vaccines, and specialized medical devices. The DLA Troop Support Medical contract represents a strategic partnership that enables efficient and flexible procurement of essential pharmaceutical commodities to support military treatment facilities and veterans' healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FA3R4?
SPE2DR26FA3R4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FA3R4 worth?
The government has obligated $33,871 on SPE2DR26FA3R4.
Is contract SPE2DR26FA3R4 an order under another contract?
Yes. SPE2DR26FA3R4 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA3R4 competed?
The extent of competition for SPE2DR26FA3R4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award